VIVO
$18.55
Meridian Bioscience
($.45)
(2.37%)
VIVO
Earnings Whisper ®
N/A
1st Quarter December 2020
Consensus:  $0.33
Revenue:  $75.13 Mil
Friday
Feb 12
7:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when VIVO reports earnings?
Beat
Meet
Miss

Where is VIVO's stock price going from here?
Up
Flat
Down
Stock chart of VIVO
Analysts
Summary of analysts' recommendations for VIVO
Score
Grade
Pivots
Resistance
$20.17
$19.72
$19.36

$18.91

Support
$18.55
$18.10
$17.74
Tweet
Growth
Description
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Peers
Myriad GeneticsCareDxQuidelSurModics